Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$8,465,159
-$1,273,319 QoQ
Shares Held
67,003
-4.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#460
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. GILD ranks #3 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,465,159 | 67,003 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $9,738,478 | 69,875 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,907,241 | 72,570 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,419,683 | 75,853 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,599,077 | 77,560 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,571,264 | 76,495 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $8,350,340 | 90,401 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $26,755,440 | 319,125 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $22,715,330 | 331,079 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $24,491,943 | 334,361 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $35,421,055 | 437,243 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $33,640,566 | 448,900 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $34,250,062 | 444,402 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $37,485,928 | 451,801 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $38,847,210 | 452,501 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $28,028,666 | 454,347 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $28,082,446 | 454,335 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $26,803,091 | 450,851 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $31,893,216 | 439,240 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $30,794,280 | 440,863 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $30,215,492 | 438,796 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $28,207,957 | 436,453 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $24,133,389 | 414,236 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $25,981,895 | 411,171 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $31,667,888 | 411,592 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $26,366,954 | 352,688 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||